Telmisartan, Amlodipine & Hydrochlorothiazide Tablets - TALMIR TRIO Tablets

TALMIR TRIO Tablets
Composition:- Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg

TALMIR TRIO Tablets – Telmisartan, Amlodipine & Hydrochlorothiazide Tablets combine the power of three proven antihypertensive agents—Telmisartan (an ARB), Amlodipine (a CCB), and Hydrochlorothiazide (a thiazide diuretic). Together, they provide a synergistic effect: Telmisartan lowers vascular resistance by blocking angiotensin II, Amlodipine relaxes arterial smooth muscle through calcium channel blockade, and Hydrochlorothiazide reduces fluid overload via diuresis. This triple therapy is designed for patients whose hypertension cannot be controlled with single or dual agents.

Key Points of Telmisartan, Amlodipine & Hydrochlorothiazide Tablets – TALMIR TRIO Tablets
• Triple-Action Control: Targets blood pressure through vasodilation, calcium channel blockade, and diuresis.
• Effective in Resistant Hypertension: Suitable for patients not responding adequately to single or dual therapy.
• Heart & Kidney Protection: Reduces cardiovascular risk and protects renal function, especially in patients with diabetes or chronic kidney disease.

Can be Prescribed by:
• Cardiologists 
• Nephrologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.